|Videos|July 24, 2018

PNH Research Update

Author(s)Aplastic Anemia, MDS International Foundation

Dr. Antonio Risitano, University of Naples and Dr. Regis Peffault DeLatour, Hospital de St. Louis, discuss recent research on treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.

Stay up to date on cancer updates, research and education

Related to this article

October 24th, 2026

What Liquid Biopsy and ESR1 Mutations Mean in Breast Cancer

An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.

October 23rd, 2026

Finding My Rhythm Again: What Fall Means to Me After Cancer

After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding support beyond treatment.

October 23rd, 2026

Psychiatrist Answers Questions About Family and Relationships During Cancer

Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.

October 23rd, 2026

Staying Active After Cancer Linked to Lower Medicare Costs

Among more than 12,000 cancer survivors 65 and older, those who stayed physically active after diagnosis tended to have lower health care costs, an American Cancer Society study published Oct. 21, 2026, in CANCER found.

October 22nd, 2026

FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors

The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.

October 22nd, 2026

Is Cancer a Hero’s Journey?

Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.